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Abstract 
This study was designed to evaluate the influence of a phytohormone, 
gibberellic acid (GA3) on marker enzymes and biomarkers of serum, and 
blood hemoglobin and its blood cells counts of rat. In order to evaluate the 
positive/negative effects, the rats were administered 75μg, 150μg and 
300μg of GA3/kg body weight as a single dose. GA3 treatments produced 
differential effects on the different parameters at dose dependent manner 
after 4 hours.   
The down regulation in specific activities of ALT, ALP, GGT and amylase 
were noted against the control with significant up regulation of AST 
activity.  GA3 also produced dose dependent effect on biomarkers.  There 
is a substantial reduction in the quantity of glucose, urea, creatinine, 
calcium, phosphorus, sodium and potassium was recorded against the 
control.  On the other hand, the insignificant increase in content of total 
protein, albumin and uric acid was observed at all dose of GA3 treatment 
against the control.  GA3 increased the RBC, WBC and neutrophil by 
decreasing the lymphocyte total numbers. Platelets, monocytes and 
oesinophils count were not altered by any dose of GA3.   
In conclusion, GA3 produced dose dependent effect on different 
parameters of rat blood serum. 
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Introduction 
Plant growth regulators (PGRs) gave entry into 
animal cells through diet. Gibberellic acid (GA3) 
is an extensively prevalent plant growth regulator 
due to its use in agriculture. It is a diterpene 
hormone derived from acetyl Co A through the 
mevalonic acid metabolic pathway in plants. GA3 
plays a significant role in plant cellular processes 
such as in cell elongation, breaking dormancy in 
seeds and buds, in flowering and parthenocarpic 
fruit development and in the mobilization of food 
reserves in grass, in seed germination and in 
juvenility and sex expression (1). GA3  is known 
to be ubiquitously present in the plant kingdom.  
 
 
Recent research has indicated that Plant growth 
regulators expressed biological potentials in 
animal cells. It is reported that fecundity, 
longevity and egg vitality in insects was affected 
by PGRs treatment (2,3). Ozmen et al (4) 
observed that abscissic acid and GA3 affected 
sexual differentiation and other physiological 
parameters of mice.  PGRs caused increase in the 
number of splenic plaque forming cells and 
circulating WBCs, hematocrit value and thymus 
weight in young deer mice (5). GA3 induced liver 
neoplasm in Egyptian toads and the tumours 
could be diagnosed as hepatocellular carcinomas 
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(6). Ustan et al (7) have reported that GA3 
induced microabsceses and hydropic 
degeneration in the liver and mononuclear 
inflammatory infiltration in the kidneys of mice. 
PGRs induced oxidative stress, leading to 
generation of free radicals and caused lipid 
peroxidation as one of the molecular mechanisms 
of in PGRs induced toxicity (8).  The long term 
use of high levels of GA3 showed a significant 
decrease in testicular weight and sperms count in 
male albino rats (9). The feeding of GA3 to Mus 
musculus doubled the proportion of females 
producing litters without increase in litter size or 
number (10). GA3 had positive influence of on 
body weight, food conversion rate and fecundity 
on rats, poultry, pigs and calves (11, 12, 13). GA3 
exhibited estrogenic hormone-like action in 
mammals (14, 15).  In castrated male rats, GA3 
partially restored the weight of prostrate but did 
not significantly change the weight of epididymis 
and seminal vesicles (16).  Gawienowski had 
clearly demonstrated that GA3 not only exihibited 
synergistic uteropic effect with estradiol in the 
immature mouse, but also expressedpossessed 
androgenic properties in male chicks (17). 
Elkomy et al demonstrated that GA3 can have 
testosterone like biological effects on male 
chicks, was noted for comb and testes weights 
and secretion of testosterone in male chicks. GA3 
exhibited a direct androgenic-like action on rabbit 
testis and a positive effect on semen quality and 
quantity (18, 19). 
 
Therefore, the present study was therefore aimed 
at investigating the short term  effect of GA3 on 
male albino rats with regard to the specific 
activities of marker enzymes (AST, ALT, ALP, 
GGT and amylase), the content of blood markers 
(hemoglobin, glucose, cholesterol, triglycerides, 
total protein, albumin, urea, uric acid and  
creatinine), serum electrolytes (sodium, 
potassium, phosphorus and calcium) and blood 
cell counts (RBC, WBC, platelets, neutrophils, 
eosinophils, monocytes and lymphocytes). This 
study highlights the nutritional and biological 
importance of understanding the influence of 
environmental (plant) factors on the biology of 
animal cell functions. 
Materials and Methods 
Materials 
Gibberellic acid (Sigma) was a gift from 
Dr.Kanabiran, Reader, Pondicherry University, 
India.   All chemicals used for this study were of 
analytical grade purchased from manufacturers in 
India.  Glass distilled water was used for the 
preparations of all reagents. Male albino wistar 
strain rats (160-180g,10-12 weeks old) were 
obtained from JIPMER, Puducherry, India. The 
rats were housed   at 20±2°C in light/dark cycles. 
All rats were fed Kamadhenu (India) rat feed 
pellet (analysed and established composition) and 
were given water ad libitum.  The care of rats 
followed `guidelines for the care and use of 
laboratory animals’ during experiments. 
 
Methods 
The rats were housed in 4 groups of 6 each.  A 
control group was given 50μl of 50% absolute 
alcohol subcutaneously to serve as control. The 
experimental group of rats was given 75μg, 
150μg and 300μg of GA3/kg body weight in 50μl 
of 50% absolute alcohol administered 
subcutaneously as a single dose. Following this 
the rats were anaesthetized 4 hours later with 
anesthetic ether and blood was collected by 
cardiac puncture. Collected blood was 
centrifuged for the preparation of serum. Blood 
collected in EDTA was used for hematological 
studies. AST and ALT enzyme activity were 
assayed by the method of Reitman and Frankel 
(20). ALP was assayed by the method of Bessey 
et al (21). GGT activity was measured by 
Orlowski and Meister method (22).  Amylase 
activity was assayed by the method of Bernfeld 
(23).  Blood hemoglobin content was estimated 
by the method of Sahli’s (24).  Glucose content 
was measured by the modified procedure of 
Asatoor and King method (25).  Cholesterol and 
triglycerides content were measured by using 
standard kits supplied by Ranbaxy Diagnostic 
Limited, Mumbai, India. Protein content was 
measured by the method of Lowry et al (26). The 
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quantity of serum albumin was measured by the 
method of Reinhold (27). Urea content was 
measured by the method of Netelson et al (28) 
and uric acid by Caraway et al (29).  Creatinine 
content was measured by the method of Owen et 
al (30). Serum content of calcium, phosphorus, 
sodium and potassium were determined by the 
procedure of Halloran et al (31). Total count of 
RBC and total and differential count of WBC 
were enumerated by the method of Chesbrough et 
al (31).  Data was expressed as mean ± Standard 
Error Mean (SEM) for six rats.  SPSS 11 program 
was used for statistical analysis. The ifference 
between control and treated values was calculated 
using one way ANOVA and statistical 
significance was noted (p<0.05*) for all the tests. 
 
Results    
Treatment of rats with GA3 caused dose 
dependent changes in the activities of serum 
enzymes (Table.1), in the content of glucose, , 
urea, uricacid, creatinine (Table.2) and in RBC, 
WBC, platelet count and in the differential counts 
of WBCs (Table.3). Treatment of rat with 
different doses of GA3 altered specific activities 
of each enzyme studied. The specific activity of 
AST showed  a marginal increase of  14.1%, 
16.5% and 2.5% respectively at 75,150 and 
300µg use of GA3 versus the  control rats. In 
contrast, the rat serum ALT, ALP, GGT and 
amylase specific activities decreased for almost 
all doses of GA3 treatment versus the respective 
controls. The ALT specific activity decreased 
(p<0.05 level) 31% for 75µg, 20% for150µg and 
6.2% for 300µg GA3 used in the study. The 
activity of GGT decreased at all does of GA3 
used with a maximum decrease (30%) at 300µg 
GA3. Amylase specific activity was marginally 
down regulated at 75µg and 150µg GA3 doses, 
while induced considerable decrease (49%)  at 
300µg of GA3 dose. 
 
Table 1:    Effect of GA3 on rat serum enzyme specific activities. 
                    GA3 treatment (µg/kg body weight)  
Enzymes Control 75µg             150µg             300µg 
AST                 3.39 ± 0.159 3.78 ± 0.182*         4.49 ± 0.203**       4.95 ± 0.238** 
ALT   0.94 ± 0.063 0.65 ± 0.045**   0.75 ± 0.041*         0.88 ± 0.053 
ALP 6.48 ± 0.380 4.41 ± 0.205**    5.96 ± 0.399 6.48 ± 0.496 
GGT               0.101 ± 0.007    0.072 ± 0.003**    0.084 ± 0.004*       0.098 ± 0.005 
Amylase 10.42 ± 0.233    9.32 ± 0.725*         9.22 ± 0.456* 5.31 ± 0.284** 
Enzyme specific activities were expressed in IU/gm of wet tissue x 10-3 
Each value represents ± SEM of 6 rats. 
*p<0.05 and **p<0.001 
Table 2: Effect of GA3 on rat serum biomarkers and mineral contents 
 GA3 treatment (µg/kg body weight) 
     Biomarkers            Control       75µg          150µg          300µg 
Glucose (mg/dl)           110.0 ± 6.73    82.0 ± 4.61**   76.0 ± 3.83**    72.0 ± 4.47** 
Total protein (gm/dl)   6.00 ± 0.44     6.72 ± 0.201*   6.60 ± 0.221     6.12 ± 0.413 
Albumin (gm/dl)          3.60 ± 0.21     4.00 ± 0.27*    3.87 ± 0.24      3.87 ± 0.24 
Urea (mg/dl)                33.0 ± 1.38     27.1 ± 1.06*    25.1 ± 1.14**    19.3 ± 1.04** 
Uric acid (mg/dl)         9.70 ± 0.69     10.9 ± 0.47     12.0 ± 0.55**    13.70 ± 0.6** 
Createnine (mg/dl)       1.01 ± 0.06     1.31 ± 0.08**   1.37 ± 0.09**    1.4 ± 0.08**   
Calcium (mg/dl)          11.30 ± 0.77    11.8 ± 1.06     10.2 ± 0.88      9.50 ± 0.48* 
Phosphorus (mg/dl)     6.12 ± 0.34     5.46 ± 0.354    5.06 ± 0.230*    4.44 ± 0.20** 
Sodium (meq/l)            147.0 ± 5.25    144.0 ± 5.59    132.0 ± 5.01*    130.0 ± 3.84* 
Potassium (meq/l         4.90 ± 0.45     4.00 ± 0.16*    3.80 ± 0.15*     3.60 ± 0.14** 
  Each value represents ± SEM of 6 rats.          *p<0.05 and **p<0.001
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Similarly, treatment of rat with different doses of 
GA3 altered the biomarker content of rat blood in 
a dose dependent manner (Table 2). There was 
however, no significant change in hemoglobin 
content due to any doses of GA3. Nevertheless, 
the blood glucose content, significantly decreased 
at all doses of GA3 such as, by 26% with 75µg, 
31% with 150µg and 49% with 300µg GA3 
compared to corresponding controls.  Serum 
cholesterol was noted to be only marginally 
increased (25%) by 300µg GA3, whereas showed 
21% for 75µg and 6.2% for 150µg GA3. Similar 
to cholesterol, the triglyceride content  also 
marginally decreased at low dose (14%) and 
increased pattern was observed for all remaining 
doses of GA3 treatments. The total serum protein 
and serum albumin content remained stationary 
for all doses of GA3 treatment.  Serum urea 
content decreased 18%, 24% and 42% at 75, 150 
and 300µg GA3 doses respectively. Creatinine, 
sodium, potassium and phosphorus content also 
noticeably decreased at all doses of GA3 
treatment in a dose dependent manner. In 
contrast, the serum uric acid content was however 
found to be increased significantly (P<0.05) at all 
doses of GA3. Gibberellic acid produced quantum 
alterations in the numbers of certain blood cells 
in a dose dependent manner (Table 3).  The RBC 
number increased 46% at 75 and 105% at 150µg 
GA3 dose. The total number of WBC also 
increased following 150µg dose of GA3. GA3 did 
not produce significant changes in platelet, 
eosinophil, and monocyte numbers. Surprisingly, 
a progressive increase followed by decrease in 
the percentage of neutrophils and lymphocytes 
respectively was noted for low to high does of 
GA3 treatment of the rats.   
 
Discussion 
Since GA3 is a popular plant growth hormone and 
information on its acute positive or negative in 
vivo effect on higher animals is almost nil this 
compound was used for the present study. The 
data collected was from a single time point by 
using different doses of GA3.  The results of this 
study cannot be compared to any other previous 
study as no previous study on short term effect of 
GA3 in rat model exists.  
 
In this study, the acute effect of GA3 on rat was 
analyzed by determining changes in selected 
enzyme activities and blood/serum markers. 
Measurement of the activities of various enzyme 
markers in the animal tissues and body fluids had 
a critical role in disease investigation and 
diagnosis (32), as also for the identification of 
drug toxicity including that of natural compounds 
(33). The present study indicated that GA3 have 
differential effects on serum and blood 
parameters in a dose dependent manner.  Each 
enzyme studied behaved differently towards 
different doses of the compound administered 
(Table 1). The marginal increase in serum AST 
activity was noted 4 hours post GA3 treatment.
 
 
Table 3: Effect of GA3 on rat serum lipid profile 
  GA3 treatment (µg/kg body weight) 
Lipid fractions      Control    75µg        150µg    300µg 
Cholesterol 
(mg/dl)             
78.0 ± 4.44         72 .0 ± 4.67          78.0 ± 4.42           84.0 ± 5.79 
Triglycerides 
(mg/dl)           
56.0 ± 3.92         54.0 ± 3.94          58.0 ± 3.69           62.0 ± 3.67 
HDL (mg/dl)        17.1 ± 0.69         21.1 ± 1.11**      20.2 ± 1.04*         20.1 ± 1.11     
LDL (mg/dl)          39.0 ± 1.12         42.0 ± 2.91          45.0 ± 2.27*         47.0 ± 2.01** 
VLDL (mg/dl)      22.1 ± 1.21           10.1 ± 0.62** 12.2 ± 0.61**       17.2 ± 1.04**       
  Each value represents ± SEM of 6 rats. 
   *p<0.05 and **p<0.001. 
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Table 4: Effect of GA3 on rat blood cells count. 
                  GA3 treatment (µg/kg body weight) 
Blood cells                     Control   75µg   150µg         300µg 
RBC (x106/cumm) 5.9 ± 0.24     8.73 ± 0.29**   8.27 ± 0.336**   6.82 ± 0.32* 
WBC (x103/cumm)       6.00 ± 0.24    5.15 ± 0.27*     6.29 ± 0.37         7.7 ± 0.30** 
Platelets (x 
105/cumm)            
2.72 ± 0.18    1.62 ± 0.07**   2.01 ± 0.07**     2.85 ± 0.20    
Neutrophils( %)             52.0 ± 4.25    58.0 ± 3.77       62.0 ± 2.68*       64.0 ± 3.68*   
Eosinophils( %)             2.0 ± 0.13      2.0 ± 0.13         2.0 ± 0.26           2.0 ± 0.12 
Monocytes(%)               1.0 ± 0.13      1.0 ± 0.14         1.0 ± 0.16           1.0 ± 0.13 
Lymphocytes(%)           46.0 ± 2.28    40.0 ± 3.55*     35.0 ± 1.02*       34.0 ± 1.26* 
Hemoglobin (gm%)       13.9 ± 1.04    14.6 ± 0.91       14.0 ± 1.17         13.1 ± 1.11     
   Each value represents ± SEM of 6 rats. 
   *p<0.05 and **p<0.001. 
 
The concrete reason for such a change is not 
clearly understood. The significant increase in 
serum AST activity denoted increased release of 
this enzyme from tissues as well as due to the 
increased transaminase activity. It may also be 
due to the effect of GA3 on tissues with the 
possibility of damage of the cardiac and hepatic 
tissues of rat, as they remain the prime source for 
serum AST activity. Serum enzymes are 
generally derived from tissues through extrusion 
and damage to cell membranes (34).  It may also 
be possibly mediated by changes in the aspartate 
amino transferase metabolism in the cardiac and 
liver tissue caused by GA3. Reson et al reported 
that increase of transaminase activities were 
related to aminoacid imbalance that initiated 
protein catabolism (34). Therefore, enzymes from 
diseased tissues and organs may manifest in the 
serum, resulting in increased serum enzyme 
activity. Alterations in biochemical as well as 
haematological parameters may be considered 
toxicity indices of compounds/drugs as result of 
their chronic use (35). On the other hand, 
reduction in the activities of serum ALT, ALP, 
GGT and amylase was noted in GA3 treated rats, 
surprisingly below the control values. The 
specific reason for this observation is not 
presently known.  This decrease in enzyme 
activity may possibly be due to decreased 
synthesis and release of these enzymes from their 
sources and or inhibition or reduction of enzyme 
activities. Serum content of these enzyme 
activities reflected the overall status of the animal 
health when subjected to exogenous modulants, 
infection or injury.  Decreased transaminase 
levels are commonly observed for substances that 
induced liver cytochrome P450. Down regulation 
of ALT synthesis would affect the ability of the 
liver to metabolize amino acids for energy 
production in the cell.  This would limit the 
capacity of the hepatocytes to generate 
appropriate energy levels in this tissue through 
pyruvate generation. Gamma glutamyl 
transpeptidase, activity found highest in the 
kidney, was significantly reduced with medium 
and higher doses of GA3.  The decrease in activity 
of this enzyme may probably be due to an 
imbalance in metabolism of glutathione that is 
needed for detoxification of foreign compounds. 
There was also significant reduction in amylase 
enzyme activity recorded using 300µg of GA3. 
GA3’s suppressive effect on amylase is probably 
through encouraging tissue lipogenesis. 
 
A progressive decrease in the quantity of glucose 
was noted at all doses of GA3 treatment. This 
may be lead to a hypoglycemic effect of GA3 on 
rat tissues. Further it suggests increased glucose 
utilization by cells resulting in greater glucose 
entry into the cells of each tissue. Utilization of 
the G-6-P generated, either through the glycolysis 
or through the HMP pathway remains the 
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established biochemical measure to counteract 
enhanced glucose load in tissues. In contrast, the 
amount of total free cholesterol and triglyceride 
in the serum of rat was found to be elevated when 
300µg of GA3 was used. The reason for an 
elevated cholesterol and triglyceride due to GA3 
possibly represents increased mobilization of 
these lipids from tissues, or due to their decreased 
transport from blood to tissues. The total protein 
and albumin content was not significantly altered 
by any dose of GA3, indicating that the protein 
metabolism was not affected by GA3.  
 
Urea, an end product of protein metabolism, was 
significantly reduced at all doses of GA3 
treatment, a positive indication of normal kidney 
function with no adverse effect on protein 
metabolism. From the above facts it is clearly 
understood that the GA3 treatments did not 
produce significant changes in protein 
metabolism. The amount of urea excretion 
depended upon the glomerular filtration rate and 
when this process failed, the plasma urea level 
gets raised.  Uric acid, the end product of purine 
metabolism has proved to be a selective 
antioxidant, capable especially of reacting with 
hydroxy radicals and hypochlorous acid46.  
Increased level of uric acid in GA3 treated rats 
was noted in this study. A reduction in MDA 
content was also noted in all the tissues studied 
for the different doses of GA3 treatment (data not 
shown).  There seems to be correlation between 
increase in uric acid and the decrease in MDA 
content noted in this study. The serum creatinine 
was found to be reduced by GA3 treatment. 
Serum creatinine level and BUN are the only 
parameters used for the determination of 
nephrotoxicity47. BUN is produced endogenously 
by tissue creatinine breakdown, and a change 
increase in serum creatinine level depended upon 
the glomerular filtration rate.  When creatinine 
excretion failed to balance the production, serum 
creatinine level increased (36).  Results of this 
study led to conclude that GA3 promoted greater 
creatinine excretion. GA3 treatment also were 
reduced the content of serum minerals. The 
reason for the reduction in the quantity of 
sodium, potassium, calcium and phosphorus 
noted was not clearly understood. It may be due 
to alterations in the permeability of electrolytes 
across cell membranes/ or due to abberations in 
the membrane ATPase function. A decrease in 
these ions may lead to severe complications in 
body functions.  
 
The total numbers of RBC, WBC and neutrophil 
were significantly increased at all doses of GA3 
treatment, possibly due to an action of GA3 on 
hemopoiesis.  Decrease in platelet counts except 
at 75 and 300µg GA3 dose and of lymphocytes at 
all doses of GA3, while the eosinophil and 
monocyte numbers remained stationary.  Reason 
for the differential response of blood cells to 
exogenous GA3 administration was not clear. In 
conclusion, treatment of rat with GA3 produced 
dose dependent effect on serum enzymes and 
blood markers. This study highlights the possible 
varied effects of GA3 in the rat and possibly in 
other mammals as a short term response to its 
presence in the animal tissue. Further detailed 
study is required to report on its wider effects. 
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